November 9, 2020 – BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) has appointed Paddy O’Brien as worldwide president, Peripheral Intervention, effective October 24.
In his new role, O’Brien will have responsibility for driving global strategic, operational and commercial performance across the Peripheral Intervention portfolio, which includes focused areas of oncology, peripheral arterial disease and end-stage kidney disease.
O’Brien has been with BD for over two decades, most recently, he was VP and general manager for the global platform focused on solutions for peripheral arterial disease and end-stage kidney disease.